Cypherpunk Technologies Inc
Company Profile
Business description
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
Contact
47 Thorndike Street
Suite B1-1
CambridgeMA02141
USAT: +1 617 714-0360
Sector
Financial Services
Stock type
Cyclical
Industry
Asset Management
Fiscal Year End
31 December 2026
Employees
6
Stocks News & Analysis
stocks
The strange effect of the 30% minimum capital gains tax
stocks
Major ASX miner reduces aluminium exposure
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,004.70 | 38.80 | -0.43% |
| CAC 40 | 8,500.91 | 21.04 | 0.25% |
| DAX 40 | 25,630.59 | 187.30 | -0.73% |
| Dow JONES (US) | 53,199.62 | 143.71 | 0.27% |
| FTSE 100 | 10,742.80 | 91.03 | 0.85% |
| HKSE | 23,496.89 | 119.43 | -0.51% |
| NASDAQ | 25,937.57 | 183.59 | -0.70% |
| Nikkei 225 | 68,256.96 | 1,480.73 | -2.12% |
| NZX 50 Index | 13,762.79 | 0.31 | -0.00% |
| S&P 500 | 7,522.42 | 15.01 | -0.20% |
| S&P/ASX 200 | 8,803.90 | 35.50 | -0.40% |
| SSE Composite Index | 3,990.24 | 51.00 | -1.26% |